MLL Becomes Functional through Intra-Molecular Interaction Not by Proteolytic Processing

• Akihiko Yokoyama ,

  * E-mail: yokoyama@dsk.med.kyoto-u.ac.jp (AY); mcleary@stanford.edu (MLC)

  Affiliation Laboratory for Malignancy Control Research, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Francesca Ficara,

  Affiliations Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, Italy, Humanitas Clinical and Research Center, Rozzano, Italy

  ⨯
• Mark J. Murphy,

  Affiliation Department of Pathology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Christian Meisel,

  Affiliation Depertment of Neurology, University Clinic Carl Gustav Craus, Dresden, Germany

  ⨯
• Chikako Hatanaka,

  Affiliation Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan

  ⨯
• Issay Kitabayashi,

  Affiliation Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan

  ⨯
• Michael L. Cleary

  * E-mail: yokoyama@dsk.med.kyoto-u.ac.jp (AY); mcleary@stanford.edu (MLC)

  Affiliation Department of Pathology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯